Changxian Shen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Cell Proliferation

Dna Damage Response

Top Venues

Scientific reports

Clinical cancer research : an official journal of the American Association for Cancer Research

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Terence M Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten E Weber, Peter Andreas Fasching, Carsten Denkert, Jenny Furlanetto, Ernst Heinmöller, Sabine Schmatloch, Thomas Karn, Christopher W Szeto, Marion T van Mackelenbergh, Valentina Nekljudova, Elmar Stickeler, Patrick Soon-Shiong, Christian Schem, Thomas Mairinger, Volkmar Mueller, Frederic Marmé, Michael Untch, Sibylle Loibl
Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Linlin Yang, Changxian Shen, Adriana Estrada-Bernal, Ryan Robb, Moumita Chatterjee, Nikhil Sebastian, Amy Webb, Xiaokui Mo, Wei Chen, Sunil Krishnan, Terence M Williams
Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair. Nucleic acids research 49 (19) (2021)
Xianjin Wu, Shenghua Li, Xing Hu, Xiaoliang Xiang, Megan Halloran, Linlin Yang, Terence M Williams, Peter J Houghton, Changxian Shen, Zhengfu He
mTOR Signaling Upregulates CDC6 via Suppressing miR-3178 and Promotes the Loading of DNA Replication Helicase. Scientific reports 9 (1) (2019)